NCT00847249 AZD9164 Single Ascending Dose Study in Healthy Male Subjects Status COMPLETED Phase PHASE1
NCT00846976 Treatment Protocol to Monitor the Safety of a 200 mg Dose of Bicalutamide in Patients With Advanced Prostate Cancer Status COMPLETED Phase PHASE3
NCT00844103 Study to Investigate the Safety, Tolerability and Pharmacokinetics of Multiple Doses of AZD8566. Status COMPLETED Phase PHASE1
NCT00842855 Partial Response to PPI Treatment: The Cost to Society and the Burden to the Patient - a Study in France Status COMPLETED Phase N/A
NCT00842556 Pharmacokinetic Drug Interaction Study of Dapagliflozin and Glimepiride or Sitagliptin in Healthy Subjects Status COMPLETED Phase PHASE1
NCT00842387 Evaluation Study of a Management Strategy for Gastroesophageal Reflux Disease (GERD) Status COMPLETED Phase N/A
NCT00841048 Phase I Study in Healthy Volunteers to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD4017 After Repeated Ascending Oral Doses Status COMPLETED Phase PHASE1
NCT00839683 Pharmacokinetic Drug Interaction Study of Dapagliflozin and Valsartan or Simvastatin in Healthy Subjects Status COMPLETED Phase PHASE1
NCT00838877 Positron Emission Tomography (PET) Study With [18F]AZD4694 and [11C]AZD2184, Candidate PET Ligands for Aβ Amyloid Status COMPLETED Phase PHASE1
NCT00837967 Study to Investigate the Safety and Efficacy of High Dose of Symbicort® SMART in Japanese Patients Status COMPLETED Phase PHASE3
NCT00837720 Evaluation of Atacand® (Candesartan) in Daily Medical Practice Status COMPLETED Phase N/A
NCT00837629 Evaluation of Symbicort® Turbuhaler® (Budesonide/Formoterol) in Chronic Obstructive Pulmonary Disease (COPD) Status COMPLETED Phase N/A
NCT00836160 Comparing Efficacy Between Anti-microtubule and Non-anti-microtubule as 3th Therapy After 2nd Line EGFR-TKI Therapy Status COMPLETED Phase N/A
NCT00833456 NIS to Observe Improvement in Global Assessment of Functioning in Patients With Schizophrenia Status COMPLETED Phase N/A
NCT00832221 Positron Emission Tomography (PET) Study With [11C]Raclopride to Determine Central D2 Dopamine Occupancy of SEROQUEL Status COMPLETED Phase PHASE1